Morphology and neurochemical characteristics of the vulnerable neurons in brain aging and alzheimer’s disease

European Neurology

Volumn 37, Issue 2, 1997, Pages 71-81

  Hof, Patrick R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer s disease; Brain aging; Cortical circuits; Dementing disorders; Neurofilament protein; Pyramidal neurons; Vulnerability

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN DEGENERATION; CELL AGING; CYTOARCHITECTURE; DISEASE PREDISPOSITION; HIPPOCAMPUS; HUMAN; MORPHOLOGY; NEOCORTEX; NERVE CELL; NEUROCHEMISTRY; NEUROPATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY;

AGED; ALZHEIMER DISEASE; BRAIN; CELL AGING; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEUROFILAMENT PROTEINS;

EID: 0031046727     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117414     Document Type: Article

References (90)

1. Moss MB, Albert MS: Alzheimer's disease and other dementing disorders: in Albert MS, Moss MB (eds): Geriatric Neuropsychology, New York, The Guilford Press, 1988, pp 145-178.
2. Hof PR, Morison JH: The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions: in Terry RD, Katzman R, Bick KL (eds): Alzheimer Disease, New York, Raven Press, 1994, pp 197-229.
3. Hof PR, Cox K, Morrison JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer’s disease: I, Superior frontal and inferior temporal cortex, J Comp Neurol 1990:301:44-54.
4. Hof PR, Morrison JH: Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease, II, Primary and secondary' visual cortex, J Comp Neurol 1990;301:55-64.
5. Morrison JH: Differential vulnerability, connectivity, and cell typology, Neurobiol Aging 1993:14:51-54.
6. Brion JP: Molecular pathology of Alzheimer amyloid and neurofibrillary tangles, Semin Neurosci 1990:2:89-100.
7. Vickers JC, Dclacourtc A, Morrison JH: Progressive transformation of the cytoskelcton associated with normal aging in Alzheimer's disease, Brain Res 1992:594:273-278.
8. Terry RD, Peck A, DcTeresa R, Schechtcr R, Horoupian DS: Some morphometric aspects of the brain in senile dementia of the Alzheimer's type, Ann Neurol 1981;10:184-192.
9. Mountjoy CQ, Roth M, Evans NJR, Evans HM: Cortical neuronal counts in normal elderly controls and demented patients, Neurobiol Aging 1983:4:1-11.
10. Terry RD, Masliah E, Salmon DP, Butters N, DcTeresa R, Hill R, Hansen LA, Katzman R: Physical basis of cognitive alterations in Alzheimer’s disease: Synapse loss is the major correlate of cognitive impairment, Ann Neurol 1991:30:572-580.
11. Masliah E, Terry RD, Alford M, DcTeresa R, Hansen LA: Cortical and subcortical patterns of svnaptophvsin-like immunorcactivity in Alzheimer's disease, Am J Pathol 1991:138: 235-246.
12. Rogers J, Morrison JH: Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease, J Neurosci 1985:5:2801-2808.
13. Pearson RCA, Esiri MM, Idioms RW, Wilcock GK, Powell TPS: Anatomical correlates of the distribution of the pathological changes in the ncocortex in Alzheimer disease, Proc Natl Acad Sci USA 1985:82:4531-4534.
14. Duyckaerts C, Idauw JJ, Bastenaìre F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Ber-thaux P: Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer tvpe, Acta Neuropalhol 1986:70:249-256.
15. Lewis DA, Campbell MJ, Terry RD, Morrison JII: Laminar and regional distribution of neurofibrillary tangles and ncuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices, J Neurosci 1987:7:1799-1808.
16. Braak H, Braak E, Kalus P: Alzheimer’s disease: Areal and laminar pathology in the occipital isocortex, Acta Neuropathol 1989:77:494-506.
17. Morrison JH, Lewis DA, Campbell MJ, Hunt-Icy GW, Benson DL, Bouras C: A monoclonal antibody to non-phosphorylated neurofilamcn! protein marks the vulnerable cortical in Alzheimer’s disease, Brain Res 1987:416:331-336.
18. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoescn GW: The topographical and neu-roanatomical distribution of neurofibrillary tangles and ncuritic plaques in the cerebral cortex of patients with Alzheimer's disease, Cercb Cortex 1991;1:103-116.
19. Fcllcman DJ, Van Essen DC: Distributed hierarchical processing in the primate cerebral cortex, Cereb Cortex 1991:1:1-47.
20. Hof PR, Morrison JH: Neurofilament protein defines regional patterns of cortical organization in the macaque monkey visual system: A quantitative immunohistochcmical analysis, J Comp Neurol 1995;352:161-186.
21. Walker LC, Kitt CA, Cork LC, Slruhie KG, Dcllovado TL, Price DL: Multiple transmitter systems contribute neuntes to individual senile plaques, J Neuropathol Exp Neurol 1988:47: 138-144.
22. Hyman BT, Van Hoesen GW, Damasio AR: Memory-related neural systems in Alzheimer’s disease: An anatomic studv, Neurology 1990: 40:1721-1730.
23. Hyman BT, Damasio AR, Van lloesen GW, Barnes CL: Alzheimer’s disease: Cell specific pathology isolates the hippocampal formation, Science 1984:225:1168-1170.
24. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR: Perforant pathway changes and the memory impairment of Alzheimer’s disease, Ann Neurol 1986;20:472-481.
25. Senut MC’, Roudier M, Davous P, Fallct-Bian-co C, Lamour Y: Senile dementia of the Alzheimer type: Is there a correlation between entorhinal cortex and dentate gyrus? Acta Neuropathol 1991:82:306-315.
26. Hof PR, Perl DP, Locr/.cl AJ, Morrison JH: Neurofibrillary' tangle distribution in the cerebral cortex of parkinsonisnt-dcmentia eases from Guam: Differences with Alzheimer’s disease, Brain Res 1991;564:306-313.
27. Hof PR, Delacourte A, Bouras C: Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy: A quantitative analysis of six cases, Acta Neuropathol 1992:84:45-51.
28. Hof PR, Charpiot A, Delacourte A, Buée L, Purohit D, Perl DP, Bouras C: Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism, Ncurosci Lett 1992:139:10-14.
29. Hof PR, Bouras C, Buée L, Delacourte A, Perl DP, Morrison JH: Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer’s disease cases, Acta Neuropathol 1992:85:23-30.
30. Hof PR, Bouras C, Perl DP, Morrison JH: Quantitative neuropathologic analysis of Pick’s disease cases: Cortical distribution of Pick bodies and coexistence with Alzheimer's disease, Acta Neuropathol 1994;87:115-124.
31. Jones EG, Wise SP: Size, laminar and columnar distribution of efferent cells in the sensory-motor cortex of monkeys,.1 Comp Neurol 1977;175:391-438.
32. Benson DE, Davis RJ, Snyder BD: Posterior cortical atrophv, Arch Neurol 1988:45:789-793.
33. Hof PR, Bouras C, Constantinidis J, Morrison JH: Balint’s syndrome in Alzheimer's disease: Specific disruption of the occipito-parictal visual pathway, Brain Res 1989:493:368-375.
34. Hof PR, Bouras C, Constantinidis J, Morrison JH: Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome, J Neuropathol Exp Neurol 1990:49:168-184.
35. Hof PR, Archin N, Osmand AP, Dougherty GH, Wells C, Bouras C, Morrison JH: Posterior cortical atrophy in Alzheimer’s disease: Analysis of a new case and re-evaluation of a historical report, Acta Neuropathol 1993:86: 215-223.
36. Graff-Radford NR, Bolling JP, Earnest IV F, Shuster EA, Caselli RJ, Brazis PW: Simulta-nagnosia as the initial sign of degenerative dementia, Mayo Clin Proc 1993:68:955-964.
37. Levine DN, Lee JM, Fisher CM: The visual variant of Alzheimer's disease: A clinicopatho-logic case study, Neurology 1993:43:305-313.
38. Mishkin M, Ungcrleidcr LG, Macko KA: Object vision and spatial vision: Two cortical pathways, T rends Neurosci 1983:6:414-417.
39. Van Essen DC, Maunsell JHR: Hierarchical organization and functional streams in the visual cortex, Trends Neurosci 1983:6:370-375.
40. DcYoe EA, Van Essen DC: Concurrent processing streams in monkey visual cortex, Trends Neurosci 1988;! 1:219-225.
41. Livingstone M, Hubei D: Segregation of form, color, movement, and depth: Anatomy, physiology, and perception, Science 1988:240:740-749.
42. Watson JDG, Myers R, Frackowiak RSJ, Haj-nal JV, Woods RP, Mazziotta JC, Shipp S, Zcki S: Area V5 of the human brain: Evidence from a combined study using positron emission tomography and magnetic resonance imaging, Cereb Cortex 1993:3:79-94.
43. Clarke S, Miklossy J: Occipital cortex in man: Organization of callosal connections, related myelo- and cytoarchitcelure, and putative boundaries of functional visual areas, J Comp Neurol 1990;298:188-214.
44. Baleydier C, Mauguierc F: Network organization of the connectivity between parietal area 7, posterior cingulate cortex and medial pulvinar nucleus: A double fluorescent tracer study in monkey, Exp Brain Res 1987;66:385-393.
45. Tomlinson BE, Blessed G, Roth M: Observations on the brains of non-demenied old people, J Neurol Sci 1968;7:331-356.
46. Arriagada PV, Growdon JH, Hedlev-White ET, Hyman BT: Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease, Neurology 1992:42:631-639.
47. Crystal II, Dickson D, Fuld P, Masur D, Scott R, Mchler M, Masdcu J, Kawas C, Aronson M, Wolfson L: Clinico-pathologic studies in dementia: Nondcmcntcd subjects with pathologically confirmed Alzheimer's disease, Neurology 1988:38:1682-1687.
48. Morris JC, McKccl Jr DW, Storandt M, Rubin EH, Price JL, Grant EA, Ball MJ, Berg L: Very mild Alzheimer’s disease: Informant-based clinical, psychometric, and pathologic distinction from normal aging, Neurology 1991;41: 469-478.
49. Price JL, Davis PB, Morris JC, While DL: The distribution of tangles, plaques and related im-munohistochemical markers in healthy aging and Alzheimer's disease, Neurobiol Aging 1991:12:295-312.
50. Arriagada PV, Marloff K, Hyman BT: Distribution of Alzhcimer-tvpe pathologic changes in nondcmcntcd elderly individuals matches the pattern in Alzheimer’s disease, Neurology 1992:42:1681-1688.
51. Hof PR, Biercr LM, Perl DP, Delacourte A, Buie L, Bouras C, Morrison JH: Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-ycar-old patient with preclinica! signs of dementia-Regional and laminar distribution of neurofibrillary tangles and senile plaques, Arch Neurol 1992:49:946-953.
52. Bouras C, Hof PR, Morrison JH: Neurofibrillar tangle densities in the hippocampal formation in a non-demcnted population define subgroups of patients with differential early pathologic changes, Neurosci Lett 1993:153:131-135.
53. Bouras C, Hof PR, Giannakopoulos P, Michel JP, Morrison JH: Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital, Ccrcb Cortex 1994:4:138-150.
54. Biercr LM, Hof PR, Purohit DP, Carlin L, Schmcidlcr J, Davis KL, Perl DP: Neocortiea! neurofibrillary tangles correlate with dementia severity in Alzheimer’s disease, Arch Neurol 1995:52:81-88.
55. Braak H, Braak E: Neuropalhological stageing of Alzheimer-related changes, Acta Ncuropa-lliol 1991:82:239-259.
56. Morris JC, Storandt M, McKeel Jr DW, Rubin EH, Price JL, Grant EA, Berg L: Cerebral amyloid deposition and diffuse plaques in ‘normal’ aging: Evidence for presymptomatic and very mild Alzheimer’s disease, Neurology 1996:46: 707-719.
57. West MJ, Coleman PD, Flood DG, Troncoso JC: Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease, Lancet 1994:344:769-772.
58. Berg L, McKeel DW, Miller P, Baty J, Morris JC: Neuropalhological indexes of Alzheimer’s disease in demented and non-demcnted persons aged 80 years and older, Arch Neurol 1993, 50:349-358.
59. Bcckcr JT, Mintun MA, Aleva K, Wiseman MB, Nichols T, DeKosky ST: Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer’s disease, Neurology 46:692-700.
60. Hänninen T, Hallikainen M, Koivisto K, Hel-kala EL, Reinikainen KJ, Soininen H, Myk-känen L, Laakso M, Pyörälä K, Riekkinen PJ Sr: A follow-up study of age-associated memory impairment: Neuropsychological predictors of dementia, J Am Geriatr Soc 43:1007-1015.
61. Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, McDonald B, Moly-neux AJ: Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease, Lancet 1994;343:829-830.
62. Campbell MJ, Morrison JH: A monoclonal antibody to ncurofilamcnt protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortcx, J Comp Neurol 1989:282:191-205.
63. Trojanowski JO- Schmidl ML, Shin RW, Bramblett GT, Rao D, Lee VMY: Altered tan and ncurofilament proteins in neurodcgenera-tive diseases: Diagnostic implications for Alzheimer's disease and Levvy body dementias, Brain Pathol 1993:3:45-54.
64. Hof PR, Mufson EJ, Morrison JH: The human orbitofronlal cortex: Cytoarchitecture and quantitative immunohistochemical parcella-tion, J Comp Neurol 1995;359:48-68.
65. Hof PR, Nimchinsky EA, Morrison JH: Neuro-chemical phenotype of corticocortical connections in the macaque monkey: Quantitative analysis of a subset of ncurofilament protein-immunoreactivc projection neurons in frontal, parietal, temporal, and cingulate cortices, J Comp Neurol 1995:362:109-133.
66. Nimchinsky EA; Hof PR, Young WG, Morrison JH: Neurochemical, morphologic and laminar characterization of cortical projection neurons in the cingulate motor areas of the macaque monkey, J Comp Neurol 1996:374:136-160.
67. Vickers JC, Riedcrcr BM, Marugg RA, Buée-Scherrcr V, Buée L, Delacourte A, Morrison JH: Alterations in neurofilament protein im-munoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease, Neuroscience 1994;62:1-13.
68. Vickers JC, Morrison JH, Friedrich VL Jr, Elder GA, Perl DP, Katz RN, Lazzarini RA: Age-associated and eell-type-specific neurofibrillary pathology in transgenic mice expressing the human midsized ncurofilament subunit, J Neurosci 1994:14:5603-5612.
69. Hof PR, Morrison JH: Ncocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer’s disease, Exp Neurol 1991; 111:293-301.
70. Hayes TL, Lewis DA: Nonphosphorylatcd neu-rofllament protein and calbindin immuno-rcactivity in layer III pyramidal neurons of human neocortex, Cereb Cortex 1992:2:56-67.
71. Grcenamyrc JT, Penney JB, Young AB, D’Amato CJ, Hicks SP, Shoulson I: Alterations in /.-glutamate binding in Alzheimer's and Huntington's diseases, Science 1985:227: 1469-1499.
72. Choi DW: Glutamate neurotoxicity and diseases of the nervous svstem, Neuron 1988:1: 623-634.
73. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegcnerative diseases, Trends Pharmacol Sei 1991:11:54-61.
74. Dewar D, Chalmers DT, Graham DI, McCul-loch J: Glutamate metabotropic and AM PA binding sites are reduced in Alzheimer's disease: An autoradiographic study of the hippocampus, Brain Res 1991:553:58-64.
75. Conti F, Fabri M, Manzoni T: Immunocvto-chcmical evidence for glutamatergic corticocortical connections in monkeys, Brain Res 1988:462:148-153.
76. De Boni U, Crapper McLachlan DR: Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons by glutamate and aspartate, J Neurol Sei 1985: 68:105-118.
77. Sauticre PE, Sindou P, Couratier P, Hugin J, Wattez A, Delacourte A: Tau antigenic changes induced by glutamate in rat primary culture model: A biochemical approach, Neurosci Lett 1992;140:206-210.
78. Mattson MP, Cheng B, Davis D, Bryant K, Lie-bcrburg I, Rydel RE: ß-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxic-ity, J Neurosci 1992:12:376-389.
79. Kowall NW, Beal MF: Glutamate-, glutamin-asc-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer’s disease, Ann Neurol 1991:29:162-167.
80. Hyman BT, Van Hoesen GW, Damasio AR: Alzheimer’s disease: Glutamate depletion in the hippocampal perforant pathway zone, Ann Neurol 1987;22:37-40.
81. Vickers JC, Huntley GW, Hof PR, Bederson J, DeFclipe J, Heinemann SF, Morrison JH: Int-munocytochemical localization of non-NMDA ionotropic excitatory amino acid receptor subunits in human neocorlex, Brain Res 1995.671: 175-180.
82. Huntley GW, Vickers JC, Morrison JH: Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: Organizational features related to cortical circuitry, function and disease, Trends Neurosci 1994:17:536-543.
83. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH: Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer’s disease, J Neuropathol Exp Neurol 1991:50:451-462.
84. Hof PR, Nimchinsky EA, Celio MR, Bouras C, Morrison JH: Calretinin-immunoreactivc nco-cortital inlemeurons are unaffected in Alzheimer's disease, Neurosci Lett 1993; 152:145-149.
85. Celio MR: Calbindin D-28k and parvalbumin in the rat nervous system, Neuroscience 1990: 35:375-475.
86. Conde F, Lund JS, Jacobowitz DM, Baim-bridgc KG, Lewis DA: Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex: Distribution and morphology, J Comp Neural 1994:341:95-116.
87. Van Brocckhovcn C: Presenilin and Alzheimer disease, Nature Genet 1995:11:230-232.
88. Good PF, Werner P, Hsu A, Olanow CW, Perl DP: Evidence for neuronal oxidative damage in Alzheimer’s disease, Am J Pathol 1996:149: 21-28.
89. Zola-Morgan S, Squire LR, Rcmpel NL, Glower RP, Amaral DG: Enduring memory impairment in monkeys after ischemic damage to the hippocampus, J Neurosci 1992:12:2582-2596.
90. Hodges JR, Salmon DP, Butters N: Semantic memory impairment in Alzcimer's disease: Failure of access or degraded knowledge? Neu-ropsvchologia 1992:30:301-314.